NEWS
< back to news list

NanoGroup S.A.’s acquisition of bridge financing.

The Management Board of NanoGroup S.A. has received offers from investors interested in acquiring series L shares issued (on the basis of the resolution of the Extraordinary General Meeting of March 11, 2024, adopted to raise bridge financing) to purchase shares for a total issue price of PLN 1,440,000.

In addition, one of the investors filed an offer on March 25, 2024 in which he undertook:

  1. Take up new issue shares (other than series L shares) for a total amount of PLN 500,000 at an issue price of no more than PLN 1.05 per share and make an advance payment in the amount of PLN 500,000 to the Company’s bank account by September 15, 2024 in order to take up these shares,
  2. additionally acquire (in exchange for cash contribution) new issue shares in the number constituting the quotient of the amount of PLN 500,000 and the issue price of new issue shares not higher than PLN 1.05, provided that NANOSANGUIS S.A. submits an application for granting a patent for the invention developed under the NanOX project. – a subsidiary of the Issuer – an application for granting a patent for the invention developed under the NanOX project.

NanOX refers to the device and fluid system developed and under development by NANOSANGUIS S.A. for the extracorporeal storage of organs for transplantation, which the Company reported in current reports number 52 dated September 5, 2023, number 46 dated August 14, 2023, number 28 dated March 15, 2023, and number 3 dated January 19, 2023.

Copyright © NanoGroup 2024

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.